CARA WILLIAMS: Open Payments
NPI 1184389348 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 34 payments from 15 companies in 2025. Trend: 2023 $2,089 · 2024 $1,897 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $174 |
| UCB, Inc. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Mallinckrodt Hospital Products Inc. | 3 | $63 |
| ABBVIE INC. | 3 | $61 |
| GENZYME CORPORATION | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Novo Nordisk Inc | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: TAVNEOS, Bimzelx, DUPIXENT, COSENTYX, ACTHAR, SKYRIZI, BENLYSTA, OTEZLA.
Industry payments across IN — which companies pay providers there.
